Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Liabilities from Discontinued Operations (2016 - 2018)

Soleno Therapeutics (SLNO) has disclosed Liabilities from Discontinued Operations for 3 consecutive years, with 1750000.0 as the latest value for Q3 2018.

  • Quarterly Liabilities from Discontinued Operations changed N/A to 1750000.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was 1750000.0 through Sep 2018, changed N/A year-over-year, with the annual reading at 127000.0 for FY2017, 56.79% up from the prior year.
  • Liabilities from Discontinued Operations for Q3 2018 was 1750000.0 at Soleno Therapeutics, up from 1050000.0 in the prior quarter.
  • The five-year high for Liabilities from Discontinued Operations was 1750000.0 in Q3 2018, with the low at 81000.0 in Q4 2016.
  • Average Liabilities from Discontinued Operations over 3 years is 641166.67, with a median of 419500.0 recorded in 2017.
  • The sharpest move saw Liabilities from Discontinued Operations surged 56.79% in 2017, then soared 390.65% in 2018.
  • Over 3 years, Liabilities from Discontinued Operations stood at 81000.0 in 2016, then soared by 56.79% to 127000.0 in 2017, then surged by 1277.95% to 1750000.0 in 2018.
  • According to Business Quant data, Liabilities from Discontinued Operations over the past three periods came in at 1750000.0, 1050000.0, and 625000.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.